Tool-Augmented AI for Drug Discovery: An Agentic Platform for Integrated Molecule Generation and Screening
- Leili Zhang
- Bc Kwon
- et al.
- 2026
- ACS Spring 2026
Talk
Elif Eyigoz has a multi-disciplinary background with degrees in Philosophy (BA), Cognitive Science (MA), Linguistics (MA), and Computer Science (MS and PhD), and as a believer of life-long learning, she is currently a graduate student at the department of Statistics at the Columbia University.
After she completed her PhD in Computer Science, she joined IBM in 2014 as a natural language processing (NLP) algorithms developer at Watson Labs, and later joined IBM research in 2016 as a researcher.
Her current research interests include disease progression modeling, drug discovery, and applications of NLP in healthcare.